These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7930418)

  • 21. Vaccine-associated poliomyelitis in an infant with agammaglobulinemia.
    Sankano T; Kittaka E; Tanaka Y; Yamaoka H; Kobayashi Y; Usui T
    Acta Paediatr Scand; 1980 Jul; 69(4):549-51. PubMed ID: 6255734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effectiveness of different strategies of vaccine prophylaxis for poliomyelitis in the Ukraine].
    Moĭseieva HV; Zadorozhna VI
    Lik Sprava; 2002; (2):85-8. PubMed ID: 12073271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Did thalidomide promote poliomyelitis following oral poliovirus vaccination in West Berlin in 1960?
    Wyatt HV
    Perspect Biol Med; 1983; 27(1):93-106. PubMed ID: 6646984
    [No Abstract]   [Full Text] [Related]  

  • 24. The Cutter incident. Poliomyelitis following formaldehyde-inactivated poliovirus vaccination in the United States during the Spring of 1955. II. Relationship of poliomyelitis to Cutter vaccine. 1963.
    Nathanson N; Langmuir AD
    Am J Epidemiol; 1995 Jul; 142(2):109-40; discussion 107-8. PubMed ID: 7598112
    [No Abstract]   [Full Text] [Related]  

  • 25. When can we stop using oral poliovirus vaccine?
    Hull HF; Minor PD
    J Infect Dis; 2005 Dec; 192(12):2033-5. PubMed ID: 16288363
    [No Abstract]   [Full Text] [Related]  

  • 26. Polio vaccines: WHO position paper, January 2014.
    Wkly Epidemiol Rec; 2014 Feb; 89(9):73-92. PubMed ID: 24707513
    [No Abstract]   [Full Text] [Related]  

  • 27. Poliomyelitis in the USA: virtual elimination of disease caused by wild virus.
    Kim-Farley RJ; Bart KJ; Schonberger LB; Orenstein WA; Nkowane BM; Hinman AR; Kew OM; Hatch MH; Kaplan JE
    Lancet; 1984 Dec; 2(8415):1315-7. PubMed ID: 6150330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Poliomyelitis immunity status in Italian and foreign subjects.
    Tanzi ML; Bracchi U; Affanni P; Dall'Argine A; Bombarda G; Bellelli E
    Ann Ig; 1992; 4(4):191-7. PubMed ID: 1284576
    [No Abstract]   [Full Text] [Related]  

  • 29. Safety and immunogenicity of a booster dose of inactivated poliovirus vaccine produced in vero-cells.
    Haastrup E; Thierry-Carstensen B; Jensen AM; Stellfeld M; Heilmann C
    Vaccine; 2004 Feb; 22(8):958-62. PubMed ID: 15161072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Markers of poliovirus strains isolated from cases temporally associated with the use of live poliovirus vaccine: report on a W.H.O. collaborative study.
    J Biol Stand; 1981; 9(2):163-84. PubMed ID: 6165725
    [No Abstract]   [Full Text] [Related]  

  • 31. Poliovirus antibody differentiation. Methods and application for strain specific diagnosis in complications after oral vaccination.
    Kuwert E; Höher PG; Thraenhart O
    Zentralbl Bakteriol Orig A; 1976 Apr; 234(3):407-12. PubMed ID: 180727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody response of children immunized with poliovaccines: an evaluation using two strains of poliovirus type 1.
    Deshpande JM; Dave KH
    Indian J Med Res; 1992 Sep; 95():216-20. PubMed ID: 1335965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The use of inactivated polio vaccine to prevent polio paralysis associated with the vaccination of children living in orphanages].
    Ion-Nedelcu N; Crăciun D; Strebel P; Ciufecu C
    Bacteriol Virusol Parazitol Epidemiol; 1997; 42(4):243-8. PubMed ID: 9586335
    [No Abstract]   [Full Text] [Related]  

  • 34. Role of EIPV in 1988 Israel polio outbreak.
    Slater PE
    Vaccine; 1994 Apr; 12(5):476. PubMed ID: 8023559
    [No Abstract]   [Full Text] [Related]  

  • 35. Vaccine-associated paralytic poliomyelitis.
    Sepkowitz S
    Pediatrics; 1997 Jan; 99(1):145. PubMed ID: 8989358
    [No Abstract]   [Full Text] [Related]  

  • 36. Correlation between vaccine coverage against polio and circulation and genetic evolution of the poliovirus strains isolated in Romania in the framework of the global polio eradication strategy.
    Băicuş A; Persu A; Popescu M; Penciu A; Stavri S; Soare A; Grecu N; Szmal C; Oprişan G
    Roum Arch Microbiol Immunol; 2009; 68(3):145-50. PubMed ID: 20361534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and immunogenicity of inactivated poliovirus vaccine made from Sabin strains: a phase II, randomized, positive-controlled trial.
    Liao G; Li R; Li C; Sun M; Li Y; Chu J; Jiang S; Li Q
    J Infect Dis; 2012 Jan; 205(2):237-43. PubMed ID: 22158682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaccine policy changes and epidemiology of poliomyelitis in the United States.
    Alexander LN; Seward JF; Santibanez TA; Pallansch MA; Kew OM; Prevots DR; Strebel PM; Cono J; Wharton M; Orenstein WA; Sutter RW
    JAMA; 2004 Oct; 292(14):1696-701. PubMed ID: 15479934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paralytic poliomyelitis in vaccinated children.
    Dussaix E; Huault G; Landrieu P; Tardieu M; Lebon P; Menetrat JL; Celers J
    Neuropediatrics; 1987 Aug; 18(3):153-4. PubMed ID: 3683754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renaissance of an "old" vaccine.
    Sutter RW; Kew OM
    Lancet Infect Dis; 2016 Mar; 16(3):268-70. PubMed ID: 26719059
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.